Hans Bishop is the CEO of Altos Labs. Bishop is based in USA. Bishop has held the role since 2021. Bishop was educated at Brunel University London.
Hans Bishop co-founded Altos Labs and serves as President and Board Co-Chair. He previously served as CEO of GRAIL (acquired by Illumina) and co-founded and led Juno Therapeutics as President and CEO from 2013 to 2018 until its acquisition by Celgene, bringing over 30 years of biotechnology industry experience.
Recent developments
AI summary of recent coverageRecent coverage has focused on Altos Labs' ambitious mission to advance cellular rejuvenation and reverse aging-related diseases, with particular attention to the company's significant funding and high-profile leadership appointments. Coverage has documented the company's emergence from stealth mode with substantial backing and its subsequent acquisition of Dorian Therapeutics, as well as its recruitment of experienced executives from major pharmaceutical organizations. Media attention has centered on characterizing Altos Labs as a well-funded biotech venture pursuing transformative approaches to disease and aging.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Citizenship
- United Kingdom
- Education
- Brunel University London
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Hans Bishop, it will appear here — and tie into the news timeline.
Hans Bishop: FAQ
- Who is Hans Bishop?
- Hans Bishop is the President, Founder, and Board Co-Chair of Altos Labs, based in USA.
- What company does Hans Bishop lead?
- Hans Bishop is CEO of Altos Labs, a role held since 2021.
- Where was Hans Bishop educated?
- Hans Bishop studied at Brunel University London.